Royalty Pharma (RPRX) EPS (Diluted) (2020 - 2026)
Royalty Pharma's EPS (Diluted) was $0.03 in Q2 2026, down 43.9% from $0.06 a year earlier and down 93.9% from the prior quarter.
Powered by 
Analysis
Royalty Pharma (RPRX) EPS (Diluted) (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Royalty Pharma's EPS (Diluted) was $1.46 through Jun 30, 2026, down 19.6% year-over-year; for FY2025, it was $1.37, down 5.5% from FY2024.
- EPS (Diluted) shows a five-year compound annual growth rate of -12.1% (FY2020 to FY2025).
- In earlier years, EPS (Diluted) was $1.45 in FY2024 (-23.2%), $1.88 in FY2023, $0.10 in FY2022 (-93.5%) and $1.49 in FY2021 (-42.5%).
- The Q2 2026 figure marks the lowest quarterly EPS (Diluted) since Q1 2024.
- Compared with a year earlier, EPS (Diluted) was higher in three of the last seven quarters, with growth averaging 69.9%.
- The best year-over-year quarter for EPS (Diluted) over five years was Q3 2024 (growth of 665.0%); the worst was Q1 2024 (a decline of 98.6%).
- Per Business Quant data, RPRX's EPS (Diluted) in the three quarters before Q2 2026 was $0.53 (Q1 2026), $0.38 (Q4 2025) and $0.52 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 43.85 Bn | 44.35 Bn | - | 1.57 |
| 2 | Rocket Companies | 43.67 Bn | 29.35 Bn | - | 0.08 |
| 3 | Royalty Pharma | 33.56 Bn | 33.48 Bn | - | 0.03 |
| 4 | Federal National Mortgage Association Fannie Mae | 25.52 Bn | 25.52 Bn | - | 0.03 |
| 5 | Synchrony Financial | 23.24 Bn | -44.73 Bn | - | 2.59 |
| 6 | Affirm Holdings | 22.66 Bn | 16.35 Bn | - | 4.63 |
| 7 | Royal Gold | 20.35 Bn | 19.57 Bn | 390.45 Mn | 2.78 |
| 8 | Annaly Capital Management | 15.27 Bn | 6.37 Bn | - | 1.06 |
| 9 | Ares Capital | 13.74 Bn | 11.17 Bn | - | 0.24 |
| 10 | Federal Home Loan Mortgage | 12.68 Bn | -6.06 Bn | - | 0.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.03 |
| Mar 31, 2026 | 0.53 |
| Dec 31, 2025 | 0.38 |
| Sep 30, 2025 | 0.52 |
| Jun 30, 2025 | 0.06 |
| Mar 31, 2025 | 0.41 |
| Dec 31, 2024 | 0.35 |
| Sep 30, 2024 | 0.92 |
| Jun 30, 2024 | 0.17 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.82 |
| Sep 30, 2023 | 0.12 |
| Jun 30, 2023 | 0.38 |
| Mar 31, 2023 | 0.56 |
| Dec 31, 2022 | -1.04 |
| Sep 30, 2022 | 0.23 |
| Jun 30, 2022 | 0.50 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | 0.17 |
API Access
Royalty Pharma EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=RPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "RPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=RPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();